30 related articles for article (PubMed ID: 35852638)
21. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
23. Eleven metabolism‑related genes composed of Stard5 predict prognosis and contribute to EMT phenotype in HCC.
Li D; Lin X; Li J; Liu X; Zhang F; Tang W; Zhang S; Dong L; Xue R
Cancer Cell Int; 2023 Nov; 23(1):277. PubMed ID: 37978523
[TBL] [Abstract][Full Text] [Related]
24. Scintigraphic Imaging of Neovascularization With
Jin X; Dong C; Zheng K; Shi X; Liu Y; Huo L; Wang F; Li F
Front Oncol; 2021; 11():792431. PubMed ID: 35769548
[TBL] [Abstract][Full Text] [Related]
25. Macrophage Paired Immunoglobulin-Like Receptor B Deficiency Promotes Peripheral Atherosclerosis in Apolipoprotein E-Deficient Mice.
Su W; Liang L; Zhou L; Cao Y; Zhou X; Liu S; Wang Q; Zhang H
Front Cell Dev Biol; 2021; 9():783954. PubMed ID: 35321392
[No Abstract] [Full Text] [Related]
26. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
Front Oncol; 2021; 11():726018. PubMed ID: 35299934
[TBL] [Abstract][Full Text] [Related]
27. Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group.
Liu W; Yang Y; Qi S; Wang Y; He X; Zhang L; Qu B; Qian L; Hou X; Qiao X; Wang H; Li G; Zhang Y; Zhu Y; Cao J; Wu J; Wu T; Zhu S; Shi M; Xu L; Su H; Lin N; Zhu J; Li Y; Song Y
Front Oncol; 2020; 10():583050. PubMed ID: 33718104
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma.
Llovet JM; Kelley RK; Villanueva A; Singal AG; Pikarsky E; Roayaie S; Lencioni R; Koike K; Zucman-Rossi J; Finn RS
Nat Rev Dis Primers; 2021 Jan; 7(1):6. PubMed ID: 33479224
[TBL] [Abstract][Full Text] [Related]
29. Expression levels and prognostic values of annexins in liver cancer.
Zhuang C; Wang P; Sun T; Zheng L; Ming L
Oncol Lett; 2019 Dec; 18(6):6657-6669. PubMed ID: 31807177
[TBL] [Abstract][Full Text] [Related]
30. STARD5 as a potential clinical target of hepatocellular carcinoma.
Liu Q; Du X; Yu Z; Yao Q; Meng X; Zhang K; Zheng L; Hong W
Med Oncol; 2022 Jul; 39(10):156. PubMed ID: 35852638
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
